These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 16861658

  • 1. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
    Aichele D, Schnare M, Saake M, Röllinghoff M, Gessner A.
    Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
    [Abstract] [Full Text] [Related]

  • 2. Pseudomonas aeruginosa in cystic fibrosis: pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.
    Carlsson M, Shukla S, Petersson AC, Segelmark M, Hellmark T.
    J Cyst Fibros; 2011 Jul; 10(4):265-71. PubMed ID: 21463973
    [Abstract] [Full Text] [Related]

  • 3. BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.
    Schultz H, Schinke S, Mosler K, Herlyn K, Schuster A, Gross WL.
    Pediatr Pulmonol; 2004 Feb; 37(2):158-64. PubMed ID: 14730661
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin.
    Rotschild M, Elias N, Berkowitz D, Pollak S, Shinawi M, Beck R, Bentur L.
    Clin Exp Med; 2005 Jul; 5(2):80-5. PubMed ID: 16096858
    [Abstract] [Full Text] [Related]

  • 5. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis.
    Dorlöchter L, Carlsson M, Olafsdottir EJ, Røksund OD, Rosendahl K, Fluge G.
    J Cyst Fibros; 2004 Aug; 3(3):179-83. PubMed ID: 15463905
    [Abstract] [Full Text] [Related]

  • 6. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.
    Carlsson M, Eriksson L, Pressler T, Kornfält R, Mared L, Meyer P, Wiik A, Wieslander J, Segelmark M.
    J Cyst Fibros; 2007 May; 6(3):228-33. PubMed ID: 17166780
    [Abstract] [Full Text] [Related]

  • 7. Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis.
    Holzinger JM, Toelge M, Werner M, Ederer KU, Siegmund HI, Peterhoff D, Blaas SH, Gisch N, Brochhausen C, Gessner A, Bülow S.
    Elife; 2023 Jul 18; 12():. PubMed ID: 37461324
    [Abstract] [Full Text] [Related]

  • 8. BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization.
    Hovold G, Lindberg U, Ljungberg JK, Shannon O, Påhlman LI.
    Respir Med; 2020 Jul 18; 170():105994. PubMed ID: 32843162
    [Abstract] [Full Text] [Related]

  • 9. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 10. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O.
    APMIS Suppl; 2003 Nov 15; (116):1-47. PubMed ID: 14692154
    [Abstract] [Full Text] [Related]

  • 11. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI.
    Schultz H, Csernok E, Schuster A, Schmitz TS, Ernst M, Gross WL.
    Pediatr Allergy Immunol; 2000 May 15; 11(2):64-70. PubMed ID: 10893006
    [Abstract] [Full Text] [Related]

  • 12. Extensive endoscopic image-guided sinus surgery decreases BPI-ANCA in patients with cystic fibrosis.
    Aanaes K, Rasmussen N, Pressler T, Segelmark M, Johansen HK, Lindberg U, Høiby N, Carlsson M, Wieslander J, Buchwald C.
    Scand J Immunol; 2012 Dec 15; 76(6):573-9. PubMed ID: 22946777
    [Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G.
    APMIS Suppl; 1995 Dec 15; 50():1-30. PubMed ID: 7756034
    [Abstract] [Full Text] [Related]

  • 14. Anti-neutrophil cytoplasmic antibodies (ANCA) in serum and bronchoalveolar lavage fluids of cystic fibrosis patients and patients with idiopathic bronchiectasis.
    Cobanoğlu N, Ozcelik U, Cetin I, Yalçin E, Doğru D, Kiper N, Bakkaloğlu A.
    Turk J Pediatr; 2010 Dec 15; 52(4):343-7. PubMed ID: 21043377
    [Abstract] [Full Text] [Related]

  • 15. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
    Song Z, Wu H, Mygind P, Raventos D, Sonksen C, Kristensen HH, Høiby N.
    Antimicrob Agents Chemother; 2005 Sep 15; 49(9):3868-74. PubMed ID: 16127064
    [Abstract] [Full Text] [Related]

  • 16. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies.
    Carlsson M, Eriksson L, Erwander I, Wieslander J, Segelmark M.
    Clin Exp Rheumatol; 2003 Sep 15; 21(6 Suppl 32):S95-100. PubMed ID: 14740434
    [Abstract] [Full Text] [Related]

  • 17. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
    Schultz H, Weiss J, Carroll SF, Gross WL.
    J Leukoc Biol; 2001 Apr 15; 69(4):505-12. PubMed ID: 11310835
    [Abstract] [Full Text] [Related]

  • 18. The bovine salivary proteins BSP30a and BSP30b are independently expressed BPI-like proteins with anti-Pseudomonas activity.
    Haigh B, Hood K, Broadhurst M, Medele S, Callaghan M, Smolenski G, Dines M, Wheeler T.
    Mol Immunol; 2008 Apr 15; 45(7):1944-51. PubMed ID: 18055015
    [Abstract] [Full Text] [Related]

  • 19. BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
    Lindberg U, Carlsson M, Hellmark T, Segelmark M.
    J Immunol Res; 2015 Apr 15; 2015():947934. PubMed ID: 26273683
    [Abstract] [Full Text] [Related]

  • 20. A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow.
    Lennartsson A, Pieters K, Vidovic K, Gullberg U.
    J Leukoc Biol; 2005 Mar 15; 77(3):369-77. PubMed ID: 15590754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.